![The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk | Cleveland Clinic Journal of Medicine The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/83/5_suppl_1/S4/F2.medium.gif)
The role of hemoglobin A1c in the assessment of diabetes and cardiovascular risk | Cleveland Clinic Journal of Medicine
![Graphical representation of the pattern of hemoglobin A1c trends in... | Download Scientific Diagram Graphical representation of the pattern of hemoglobin A1c trends in... | Download Scientific Diagram](https://www.researchgate.net/publication/316944514/figure/fig1/AS:559695632048133@1510453245822/Graphical-representation-of-the-pattern-of-hemoglobin-A1c-trends-in-remitters-and.png)
Graphical representation of the pattern of hemoglobin A1c trends in... | Download Scientific Diagram
![Medicina | Free Full-Text | Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin Medicina | Free Full-Text | Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin](https://www.mdpi.com/medicina/medicina-56-00231/article_deploy/html/images/medicina-56-00231-g001.png)
Medicina | Free Full-Text | Use of Glycated Hemoglobin (A1c) as a Biomarker for Vascular Risk in Type 2 Diabetes: Its Relationship with Matrix Metalloproteinases-2, -9 and the Metabolism of Collagen IV and Elastin
![State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018 | Diabetes Technology & Therapeutics State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018 | Diabetes Technology & Therapeutics](https://www.liebertpub.com/cms/10.1089/dia.2018.0384/asset/images/medium/figure2.gif)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018 | Diabetes Technology & Therapeutics
![Serum glycated albumin to haemoglobin A1C ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus - Masafumi Koga, Jun Murai, Hiroshi Saito, Soji Kasayama, Akihisa Imagawa, Toshiaki Hanafusa, Serum glycated albumin to haemoglobin A1C ratio can distinguish fulminant type 1 diabetes mellitus from type 2 diabetes mellitus - Masafumi Koga, Jun Murai, Hiroshi Saito, Soji Kasayama, Akihisa Imagawa, Toshiaki Hanafusa,](https://journals.sagepub.com/cms/10.1258/acb.2010.009234/asset/images/large/10.1258_acb.2010.009234-fig1.jpeg)